About this trial
The aim of this observational, retrospective study is to evaluate, comparatively, procedural outcomes of APs (Accessory pathway) ablation according to the conduction properties (i.e., manifest vs. concealed) and to assess both short- and long-term outcomes of RFA (RF ablation).
Eligibility criteria
Qualifiers
EITHER clinical suspicion of paroxysmal supraventricular tachycardia without prior documentation of ventricular pre-excitation and/or supraventricular arrhythmia (SVA) on 12-lead surface electrocardiogram, OR with electrocardiographic evidence of SVA, AND electrophysiological confirmation of atrioventricular re-entrant tachycardia (AVRT) as the arrhythmic mechanism.
Aged between 5 to 60 years old
Disqualifiers
Lack of pre-specified follow-up: only patients with at least 1 years follow-up ambulatory visit will be included in the study
REDO CA procedure
Trial design
Treatments tested in this trial
- Not listed